MedRhythms Featured in “The Future Technology in Longevity Report” by The London Technology Club

October 4, 2019

PORTLAND, Maine - MedRhythms, a Portland, Maine-based digital therapeutics company, was recently featured in “The Future Technology in Longevity Report,” a paper by the London Technology Club that examined new technological approaches to increasing average lifespan. 

“MedRhythms,” the report states, “is doing hugely impactful work in the longevity/post-stroke rehab space … Its approach has the potential to impact not only chronic stroke patients but also the fall prevention and the longevity space at large.”

The London Technology Club comprises investors and tech professionals with the common goal of creating value through unique investment opportunities and networking. “The Future Technology in Longevity Report” is the fourth in a series of reports called the “Future Technology Series” by the London Technology Club. 

The report also includes a remote care section, which states that “telehealth and remote monitoring trends allow for physicians to better care for their elderly patients and to reduce the need for individuals to travel to a doctor’s office, hospital or other facility for the care they need.” Eko, which developed a remote monitoring system for the identification of cardiovascular conditions called “Eko Home,” was featured in this section of the report. Last month, Eko announced the closing of a $20MM Series B financing. This fundraising effort was led by Vas Bailey, partner at Artis Ventures.

About MedRhythms

MedRhythms, a privately held company headquartered in Portland, ME, is a digital therapeutics company that uses sensors, music, and AI to build evidence-based, neurologic interventions to measure and improve walking. The MedRhythms team has extensive experience in rehabilitation techniques that use music. The company began as a therapy services company that launched out of Spaulding Rehabilitation Hospital, which the U.S. News & World Report named the No. 3 rehabilitation hospital in the country.

For all inquiries, contact press@medrhythms.com.

Forward-Looking Statements

THIS MANAGEMENT COMMENTARY CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO THE COMPANY THAT ARE BASED ON INFORMATION AVAILABLE TO US AS OF THE DATE HEREOF. STATEMENTS THAT ARE NOT HISTORICAL FACTS, INCLUDING STATEMENTS ABOUT THE COMPANY’S BELIEFS, DESIGNS, ANTICIPATION, AIMS, GOALS, EXPECTATIONS AND POTENTIAL RESULTS ARE FORWARD-LOOKING STATEMENTS. IN ADDITION, THE WORDS “WILL,” “MAY,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “ESTIMATE,” “EXPECT,” “PROJECT,” “PLAN,” “SHOULD,” “COULD,” AND SIMILAR EXPRESSIONS, AND THEIR VARIATIONS AND NEGATIVES, AS THEY RELATE TO THE COMPANY OR THE FUTURE PERFORMANCE OF THE COMPANY, ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. SUCH FORWARD LOOKING STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER IMPORTANT FACTORS THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF RESULTS TO DIFFER MATERIALLY FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH FORWARD LOOKING STATEMENTS. THIS MANAGEMENT COMMENTARY SPEAKS ONLY AS OF THE DATE HEREOF AND THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO UPDATE THIS COMMENTARY IN THE FUTURE.